FDA clears GE's prefilled Clariscan syringes

By AuntMinnie.com staff writers

November 24, 2020 -- The U.S. Food and Drug Administration (FDA) has cleared GE Healthcare's MRI contrast agent, Clariscan, for market in prefilled syringes.

The agent comes in 10-mL, 15-mL, and 20-mL doses. It is macrocyclic and gadolinium-based and has now been approved for use in more than 70 countries around the world, the company said. It was originally cleared by the FDA in November of last year.

Copyright © 2020 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking